Director/PDMR Shareholding

Source: RNS
RNS Number : 1287V
easyJet PLC
04 August 2020
 

easyJet plc

(the "Company")

 

Director/PDMR shareholding

 

 

4 August 2020

 

The Company announces that it received notification on 4 August 2020 that Charles Gurassa, Non-Executive Deputy Chairman and Senior Independent Director, acquired 90,241 ordinary shares of 27 2/7 pence each in the Company ("Shares") at a price of £5.54 per share, in London.

 

For further details, please contact:

Michael Barker, Investor Relations

Anna Knowles, Corporate Communications

07985 890939

07985 873313

Dorothy Burwell/Ed Simpkins, Finsbury

020 7251 3801

 

The notification below is made in accordance with the requirements of the EU Market Abuse Regulation.

 

1

Details of the person discharging managerial responsibilities/person closely associates

 

a)

Name

Charles Gurassa

2

Reason for the notification

a)

Position/status

Non-Executive Deputy Chairman and Senior Independent Director

 

b)

Initial notification/ Amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

easyJet plc

 

b)

LEI

2138001S47XKWIB7TH90

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 27 2/7p

 

ISIN: GB00B7KR2P84

 

b)

Nature of the transaction

Acquisition of shares

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£5.54

90,241

 

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

90,241

 

GBP £5.54

e)

Date of the transaction

2020-08-04

 

f)

Place of the transaction

XLON

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFZGGRKDMGGZM